Apogee Acquisition Corp quarterly report, Q3 FY2026

Apogee Acquisition Corp. — Q3 2026 Form 10-Q

Reporting period: Quarter and nine months ended September 30, 2026. Filed November 13, 2026. Apogee is a Cayman Islands blank-check company seeking a business combination, with a stated focus on advanced-technology businesses. It had not begun operating activities or generated operating revenue.

Key financial metrics

MetricThree months ended September 30, 2026Nine months ended September 30, 2026
Operating expenses$101,682$459,695
Trust investment income, net of fees$1,538,596$2,974,675
Net income$1,436,914$2,514,980
Net income per redeemable share$0.08$0.24
Net loss per non-redeemable share$(0.00)$(0.03)
  • Assets and liquidity: Total assets were $176.76 million, including $176.34 million held in trust and $286,457 of cash outside the trust. Working capital was $391,731.
  • Liabilities and equity: Total liabilities were $6.03 million, including a $6.00 million deferred underwriting commission payable upon completion of a business combination. Shareholders’ deficit was $5.61 million. No borrowings or working-capital loans were outstanding.
  • Cash flow, nine months: Operating activities used $530,163; investing activities used $173.36 million, principally for trust deposits; financing activities provided $174.18 million. Cash ended the period at $286,457.
  • Profit reflects trust investment income, not operating revenue. Margins are not meaningful for this pre-combination company.

Changes, outlook and material matters

  • The IPO closed April 8, 2026: 17.25 million public units sold for $172.50 million, with another $4.70 million raised through private-placement units. The underwriters fully exercised the over-allotment option. Transaction costs totaled $8.97 million.
  • No prior-year comparable operating period is presented in the supplied financial statements; the company was formed in November 2025 and completed its IPO in April 2026.
  • Management says the company has until July 8, 2027 to complete a business combination and has no approved extension plan. Failure to complete one by then requires liquidation. Management states that $286,457 of cash outside the trust is not expected to fund operations for the next 12 months and concludes that substantial doubt exists about the company’s ability to continue as a going concern.
  • The company reported that its Q2 2026 Form 10-Q contained errors in disclosures concerning private-placement proceeds and security counts. The audit committee concluded the prior filing should no longer be relied upon; an amendment corrected disclosures but did not change the reported balance sheet, operations, equity or cash-flow amounts.
  • Disclosure controls were ineffective at September 30, 2026 due to material weaknesses involving related-party transaction identification and disclosure, review of accrued and related-party liabilities, and errors leading to the Q2 restatement. Management is implementing remediation; it has not yet established that the weaknesses are remediated.
  • Key risks include failure to find or complete a transaction, limited operating cash, potential liquidation (when warrants and rights would expire worthless), and market or geopolitical disruption. Sponsor indemnification may not fully protect trust funds because the company has not verified the Sponsor’s ability to pay.
  • After quarter-end, a director and the COO resigned in October 2026; each forfeited founder shares. The filing provides no operating forecast or transaction-specific guidance.

Important facts for investors to verify

  • Whether the July 8, 2027 deadline can be met or an extension will be proposed, and the status of any potential business-combination target.
  • How much cash is available outside the restricted trust, expected spending needs, and any proposed working-capital financing.
  • The trust balance and per-share redemption value at the time of any proposed transaction, including redemption levels and the deferred underwriting fee.
  • Progress and testing of the internal-control remediation plan, and whether future filings identify further errors or related-party disclosures.
  • Current share, warrant and right counts, including the post-quarter founder-share transfers and the potential dilution from rights and warrants if a transaction closes.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.